Poland · Delayed Price · Currency is PLN Bayer Aktiengesellschaft Company Description
Bayer Aktiengesellschaft operates as a life science company worldwide.
The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.
The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products.
The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture.
It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing.
The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers.
Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
| Country | Germany |
| Founded | 1863 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 91,864 |
| CEO | William Anderson |
Contact Details
Address: Kaiser-Wilhelm-Allee 1 Leverkusen, 51368 Germany | |
| Phone | 49 214 30 1 |
| Website | bayer.com |
Stock Details
| Ticker Symbol | BAY |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000BAY0017 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| William Anderson | Chief Executive Officer |
| Wolfgang Nickl | Chief Financial Officer |
| Sebastian Guth | Chief Operating Officer |
| Jost Reinhard | Head of Investor Relations |